Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Intellipharmaceutics (IPCI) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 73,570
  • Shares Outstanding, K 28,750
  • Annual Sales, $ 4,090 K
  • Annual Income, $ -7,440 K
  • 36-Month Beta 0.98
  • Price/Sales 29.08
  • Price/Book 41.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.46 +4.07%
on 01/18/17
3.05 -16.07%
on 12/27/16
-0.41 (-13.80%)
since 12/23/16
3-Month
2.44 +4.92%
on 11/04/16
3.35 -23.58%
on 11/25/16
-0.59 (-18.73%)
since 10/21/16
52-Week
1.41 +81.56%
on 06/14/16
3.35 -23.58%
on 11/25/16
+0.25 (+10.82%)
since 01/22/16

Most Recent Stories

More News
Research Reports Initiated on Healthcare Stocks Immunovaccine, IntelliPharmaCeutics International, Cardiome Pharma, and Aeterna Zentaris

LONDON, UK / ACCESSWIRE / January 12, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected...

Research Reports Coverage on Healthcare Stocks -- Pacira Pharma, Supernus Pharma, Lipocine, and IntelliPharmaCeutics

Stock-Callers.com today takes a closer look at the current performances of Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), Supernus Pharmaceuticals Inc. (NASDAQ: SUPN), Lipocine Inc. (NASDAQ: LPCN), and IntelliPharmaCeutics...

Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR(R) by Par Pharmaceutical

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

Intellipharmaceutics to Present at the Biotech Showcase(TM)

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

PCG Advisory Group (PCG) Announces Clients Participating During the 9th Annual Biotech Showcase(TM) Event and the 35th Annual J.P. Morgan Healthcare Conference in San Francisco

NEW YORK, NY / ACCESSWIRE / December 22, 2016 / PCG Advisory Group, a New York based leading investor and public relations firm, announces clients that will be participating in industry events around the...

Research Reports Initiated on Healthcare Stocks Cardiome Pharma, Resverlogix, IntelliPharmaCeutics International, and ProMetic Life Sciences

LONDON, UK / ACCESSWIRE / December 6, 2016 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected...

Intellipharmaceutics to Present at the LD Micro Main Event

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

Intellipharmaceutics Submits NDA for Pain Treatment Rexista

Intellipharmaceutics International Inc. (IPCI) announced that it has filed a new drug application (NDA) with the FDA for Rexista.

IntelliPharmaCeutics (IPCI) Jumps: Stock Adds 5% in Session

IntelliPharmaCeutics International Inc. (IPCI) shares rose 5% in the last trading session.

How These Healthcare Stocks are Faring? -- Alkermes, Adamis Pharma, BioScrip, and IntelliPharmaCeutics

Stock-Callers.com has initiated coverage on the following equities: Alkermes PLC (NASDAQ: ALKS), Adamis Pharmaceuticals Corp. (NASDAQ: ADMP), BioScrip Inc. (NASDAQ: BIOS), and IntelliPharmaCeutics International...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More

Business Summary

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including...

See More

Support & Resistance

2nd Resistance Point 2.66
1st Resistance Point 2.61
Last Price 2.56
1st Support Level 2.52
2nd Support Level 2.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.